Optiver Holding
MYGN icon

Optiver Holding’s Myriad Genetics MYGN Stock Holding History

Optiver Holding’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85K Sell
500
-200
-29% -$908 ﹤0.01% 2189
2026
Q1 		$3.15K Buy
700
+592
+548% +$3.08K ﹤0.01% 1634
2025
Q4 		$664 Sell
108
-356
-77% -$2.58K ﹤0.01% 2264
2025
Q3 		$3.35K Buy
+464
New +$2.75K ﹤0.01% 2103

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optiver Holding's MYGN Position: Q2 2026 in Review

Optiver Holding reduced its Myriad Genetics (MYGN) stake by 29% in Q2 2026, selling an estimated $908 and leaving 500 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

Optiver Holding first reported a position in MYGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.35K in Q3 2025. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Optiver Holding held 500 shares of Myriad Genetics worth $2.85K as of Q2 2026.
  • Optiver Holding sold 200 Myriad Genetics shares in Q2 2026, an estimated $908.
  • Myriad Genetics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2189 holding.
  • Optiver Holding first reported a position in Myriad Genetics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Myriad Genetics position peaked at $3.35K in Q3 2025.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.